Ucb (UCB.BR) traded up 5.25 % during a 24 hours period ending at 03:27 AM Central Europe on Wednesday 28th. One Ucb stock can currently be bought for about EUR 268.7 on popular exchanges. Current supply of Ucb stocks is 190.7 mn. Ucb has a current market capitalization of EUR 52 bn and approximately EUR 155.6 mn worth of Ucb was traded on exchanges in the last 24 hours. Since last month end, Ucb has traded 28.69 % up. Simple moving average of last 200 days is at EUR 241.65. The highest price of past 52 weeks was recorded at EUR 289.5 on 02/19/2026. 52 weeks low was at EUR 197.45 on 10/14/2026.
Here is how related stocks have performed in the past 24 hours:
Kbc (KBC.BR) traded up 2.66 % and now trades at EUR 116. Kbc has a market capitalisation of EUR 45.1 bn. Kbc has a current price to earnings ratio of 13.18.
Groupe Bruxelles Lambert (GBLB.BR) traded up 1 % and now trades at EUR 76.5. Groupe Bruxelles Lambert has a market capitalisation of EUR 8.9 bn.
Syensqo (SYENS.BR) traded up 0.26 % and now trades at EUR 77.15. Current market capitalisation for Syensqo is EUR 7.9 bn.
Ageas (AGS.BR) traded up 0.07 % and now trades at EUR 75.3. Ageas has a market capitalisation of EUR 15.5 bn. Ageas has a current price to earnings ratio of 7.73.
Lotus Bakeries (LOTB.BR) traded down -0.45 % and now trades at EUR 13,360. Lotus Bakeries has a market capitalisation of EUR 10.8 bn. Current price/earnings ratio for Lotus Bakeries is 56.64.
About Ucb
UCB SA is a biopharmaceutical company that specializes in the treatment of central nervous system disorders and inflammatory diseases. As a health care industry leader, UCB operates globally, serving customers worldwide with its cutting-edge products and services.